U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3000130001Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Tiotropium inhalation capsules for oral inhalationhttps://ClinicalTrials.gov/show/NCT02172326
3000230002Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy SubjectsCompletedNo Results AvailableDiabetes|HealthyDrug: semaglutidehttps://ClinicalTrials.gov/show/NCT02172313
3000330003Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Tiotropium inhalation capsules|Drug: Placebo inhalation capsuleshttps://ClinicalTrials.gov/show/NCT02172300
3000430004Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Tiotropium (Ba679 BR)|Drug: Salmeterol|Drug: Placebo (for Tiotropium )|Drug: Placebo (for Salmeterol)https://ClinicalTrials.gov/show/NCT02172287
3000530005BI 10773 Administered as Oral Solution to Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: [14C]-BI 10773 - oral solutionhttps://ClinicalTrials.gov/show/NCT02172274
3000630006Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 10773|Drug: Glimepiridehttps://ClinicalTrials.gov/show/NCT02172261
3000730007Relative Bioavailability BI 10773 and Metformin in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 10773|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT02172248
3000830008Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Pioglitazone|Drug: Pioglitazone - low dose|Drug: BI 10773 - low dose|Drug: BI 10773 - medium dose|Drug: BI 10773 - high dosehttps://ClinicalTrials.gov/show/NCT02172235
3000930009Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 10773|Drug: Linagliptinhttps://ClinicalTrials.gov/show/NCT02172222
3001030010Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 10773https://ClinicalTrials.gov/show/NCT02172209
3001130011Bioavailability of BI 10773 and Sitagliptin in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 10773|Drug: Sitagliptinhttps://ClinicalTrials.gov/show/NCT02172196
3001230012CBT Group for Adolescents With ADHD: a Randomized Controlled TrialCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Psychopharmacological treatment|Behavioral: CBT grouphttps://ClinicalTrials.gov/show/NCT02172183
3001330013Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 10773 in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: BI 10773 single rising dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02172170
3001430014Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: BI 1744 CL i.v.|Drug: BI 1744 CL oralhttps://ClinicalTrials.gov/show/NCT02172157
3001530015Via Respimat® Inhaled BI 1744 CL Compared to Moxifloxacin and Placebo in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: BI 1744 CL solution for inhalation|Drug: Placebo matching BI 1744 CL|Drug: Moxifloxacin (Avalox®)https://ClinicalTrials.gov/show/NCT02172144
3001630016Safety, Tolerability and Pharmacokinetics Study of BI 1744 CL in Healthy Male SubjectsTerminatedNo Results AvailableHealthyDrug: BI 1744 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02172131
3001730017BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal FunctionCompletedNo Results AvailableHealthyDrug: BI 1774 CLhttps://ClinicalTrials.gov/show/NCT02172118
3001830018Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1744 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02172105
3001930019Fluid Kinetics in Patients With Diabetic KetoacidosisNot yet recruitingNo Results AvailableDiabetesDrug: SodiumChloridehttps://ClinicalTrials.gov/show/NCT02172092
3002030020Mobilization With Movement for Shoulder ImpingementCompletedNo Results AvailableShoulder Impingement SyndromeOther: Real mobilization-with-movement (MWM)|Other: Sham mobilization-with-movement (MWM)https://ClinicalTrials.gov/show/NCT02172079
3002130021Narrative Exposure Therapy (NET) for Victims of the Recent Flood Disaster in BurundiCompletedNo Results AvailablePosttraumatic Stress DisorderBehavioral: Narrative Exposure Therapy (NET)https://ClinicalTrials.gov/show/NCT02172066
3002230022Resistance Exercise to Improve Fatigue in Workplace (REW)Not yet recruitingNo Results AvailableFatigue|Musculoskeletal DiseasesOther: Control Group - Training light|Other: Group Intervention - Training heavyhttps://ClinicalTrials.gov/show/NCT02172053
3002330023Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive TherapyRecruitingNo Results AvailableHypertensionDrug: Over-encapsulated 10 mg amlodipine besylate tablet|Drug: Matched placebo capsule for over-encapsulated celecoxib capsule|Drug: Over-encapsulated 200 mg celecoxib capsule|Drug: Matched placebo tablet for over-encapsulated amlodipine besylate tablethttps://ClinicalTrials.gov/show/NCT02172040
3002430024Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic ToolNot yet recruitingNo Results AvailableLung CancerDevice: Immunomagnetic Detectionhttps://ClinicalTrials.gov/show/NCT02172027
3002530025Safety and Efficacy of Fentanyl CitrateRecruitingNo Results AvailableChildrenDrug: midazolam and fentanyl citrate infusion|Drug: midazolam and normal saline infusionhttps://ClinicalTrials.gov/show/NCT02172014
3002630026A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against PlaceboWithdrawnNo Results AvailableIron Deficiency AnemiaDrug: Iron isomaltoside 1000https://ClinicalTrials.gov/show/NCT02172001
3002730027Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)RecruitingNo Results AvailablePostural Orthostatic Tachycardia SyndromeDrug: Propranolol|Drug: Bisoprolol|Drug: Propranolol+pyridostigmine|Drug: Bisoprolol+pyridostgminehttps://ClinicalTrials.gov/show/NCT02171988
3002830028Ultrasound - Guided Paramedian Techniques in Spinal AnesthesiaCompletedNo Results AvailableAnaesthesiaProcedure: pre-procedure ultrasound guided paramedian spinal|Procedure: Conventional landmark guided midline spinal anaesthetichttps://ClinicalTrials.gov/show/NCT02171975
3002930029Zilver® PTX® in ChinaRecruitingNo Results AvailablePeripheral Artery DiseaseDevice: Zilver® PTX® Drug-Eluting Peripheral Stenthttps://ClinicalTrials.gov/show/NCT02171962
3003030030Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver DiseasesRecruitingNo Results AvailableChronic Hepatitis|Hepatic CirrhosisBiological: Infusion of bone marrow mononuclear cells.https://ClinicalTrials.gov/show/NCT02171949

* Görseller ve İçerik tekif hakkına sahip olabilir